$0.65
-0.01 (-1.13%)
Open$0.65
Previous Close$0.66
Day High$0.66
Day Low$0.63
52W High$1.99
52W Low$0.53
Volume—
Avg Volume193.4K
Market Cap63.62M
P/E Ratio—
EPS$-5.24
SectorN/A
Analyst Ratings
Buy
9 analysts
Price Target
+505.7% upside
Current
$0.65
$0.65
Target
$3.93
$3.93
$2.76
$3.93 avg
$6.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.40B | 1.28B | 17.89M |
| Net Income | -558,098,633 | -458,962,691 | 2.66M |
| Profit Margin | -39.8% | -37.8% | 14.8% |
| EBITDA | -419,424,690 | -364,083,932 | 4.50M |
| Free Cash Flow | — | — | 2.54M |
| Rev Growth | +9.4% | +9.4% | -6.4% |
| Debt/Equity | 6.52 | 6.52 | 0.53 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.03 | +34.07% | — | 1.41B |
| PICS | Pics Nv | $11.49 | +0.70% | 6.6 | 1.48B |
| DMII | Drugs Made In America Acquis | $10.13 | +0.10% | 75.2 | 645.28M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.75 | +0.55% | 35.5 | 336.67M |
| CEPF | Cantor Equity Partners-Cl A | $10.39 | +0.14% | 57.9 | 595.50M |